Purpose: to evaluate the efficacy and safety of intracapsular moxifloxacin injection at the end of phacoemulsification as a prophylactic measure against early and late endophthalmitis. Setting: private eye center, eye Care, Cairo, Egypt. Methods: This is a retrospective clinical registry-based study. Data was collected from patients who had phacoemulsification within the capsular bag injection of moxifloxacin at the end of surgery. 0.2 ml of moxifloxacin 0.5% ophthalmic solution was injected into the bag by placing the tip of the cannula under the capsulorhexis edge and directing the drug behind the IOL. Results: Data were collected from EMR for 10919 eyes, that underwent phacoemulsification and in the bag moxifloxacin injection between January 2015 and August 2022, 4 cases of early endophthalmitis were reported with an incidence of 0.03%, no cases of late-endophthalmitis, and no cases of toxicity. Conclusion: Intracapsular moxifloxacin injection at the end of phacoemulsification is a safe effective prophylactic measure against endophthalmitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.